Drug Commission of German Pharmacists (AMK), Heidestraße 7.
Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
Medicine (Baltimore). 2021 Mar 19;100(11):e25144. doi: 10.1097/MD.0000000000025144.
Educational material (EM) addresses particular safety information of medicinal products to healthcare professionals and patients. Since 2016, German national competent authorities label approved EM with a Blue Hand symbol. However, data is scarce regarding its usability as a safety communication tool in pharmacies to improve patient safety. The purpose of this study is to investigate for the first time pharmacists' awareness and perception of EM in the setting of community and hospital pharmacies in Germany.The Drug Commission of German Pharmacists surveyed its nationwide network of 677 community and 51 hospital reference pharmacies, to investigate their awareness and perception of EM. The survey was conducted between January 16 and February 10, 2020 using SurveyMonkey. Data were analyzed using Microsoft Excel.A total of 373 community and 32 hospital pharmacists participated; response rates were 55.1% and 62.8%, respectively. Overall, 320 (85.8%) community and all hospital pharmacists confirmed awareness of EM. Community and hospital pharmacists fully (n = 172, 46.9% and n = 9, 28.1%) or rather (n = 109, 29.7% and n = 10, 31.3%) agreed that EM for healthcare professionals is suitable to reduce risks of medicinal products. Moreover, 237 (64.7%) community and 17 (53.1%) hospital pharmacists confirmed to inform patients or care facilities about EM. Asking pharmacists on their personal perception of EM, the refinement of readability and accessibility was indicated.Pharmacists confirm awareness of EM and its suitability as a safety communication tool. However, from a pharmacists' perspective, the applicability and readability of EM still needs further adjustment to improve patient safety.
教育材料（EM）向医疗保健专业人员和患者提供有关药品特定安全信息。自 2016 年以来，德国国家主管部门已用蓝色手符号标记批准的 EM。然而，关于其在改善患者安全性方面作为药房安全沟通工具的可用性的数据却很少。本研究的目的是首次调查德国社区和医院药房药剂师对 EM 的认识和看法。德国药剂师药物委员会对其全国范围内的 677 家社区和 51 家医院参考药房网络进行了调查，以了解他们对 EM 的认识和看法。调查于 2020 年 1 月 16 日至 2 月 10 日期间使用 SurveyMonkey 进行。使用 Microsoft Excel 分析数据。共有 373 名社区和 32 名医院药剂师参加；回应率分别为 55.1%和 62.8%。总体而言，320 名（85.8%）社区和所有医院药剂师均确认知晓 EM。社区和医院药剂师完全（n=172，46.9%和 n=9，28.1%）或相当（n=109，29.7%和 n=10，31.3%）同意 EM 适合医疗保健专业人员使用，以降低药品风险。此外，237 名（64.7%）社区和 17 名（53.1%）医院药剂师确认会向患者或护理机构告知 EM。在询问药剂师对 EM 的个人看法时，指出了可读性和可及性的改进。药剂师确认知晓 EM 及其作为安全沟通工具的适用性。然而，从药剂师的角度来看，EM 的适用性和可读性仍需要进一步调整，以提高患者安全性。
